JMP Securities Initiates Coverage On Elevation Oncology With Market Outperform Rating, Announces Price Target of $7
JMP Securities Initiates Coverage On Elevation Oncology With Market Outperform Rating, Announces Price Target of $7
JMP證券以市場跑贏大盤的評級啓動對Elevation Oncology的報道，宣佈目標股價爲7美元
JMP Securities analyst Silvan Tuerkcan initiates coverage on Elevation Oncology (NASDAQ:ELEV) with a Market Outperform rating and announces Price Target of $7.
JMP證券分析師西爾文·圖爾克坎以市場跑贏大盤的評級啓動了對Elevation Oncology（納斯達克股票代碼：ELEV）的報道，並宣佈目標股價爲7美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。